Top Markets
#1 Akedo Akedo +71.59%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.61%
#4 Cross Cross +34.10%
#5 Black Phoenix Black Phoenix +33.95%
#6 Cap Cap +29.61%
#7 Velvet Velvet +26.32%
#8 Ravencoin Ravencoin +17.91%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.35%
#10 DoubleZero DoubleZero +12.07%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lifecare AS Lifecare AS

Lifecare AS

LIFE
Rangering i aksjer #39137
Based in Norway, Lifecare AS is dedicated to the research and advancement of... Based in Norway, Lifecare AS is dedicated to the research and advancement of medical sensor technology for health tracking. A key innovation is Sencell, a compact sensor designed specifically for continuously monitoring glucose levels in diabetic patients. The company, which has its corporate headquarters in Bergen, Norway, commenced operations in 2006.
Aksjekurs
$0.03354094
Markedsverdi
$640.22K
Endring (1 dag)
0.00%
Endring (1 år)
-98.06%
Land
NO
Handel Lifecare AS (LIFE)

Kategori

Healthcare
Inntekter for Lifecare AS (LIFE)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Lifecare AS er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Lifecare AS fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US